Patients with type 2 diabetes mellitus present similar immunological response to COVID-19 BNT162b2 mRNA vaccine to healthy subjects: a prospective cohort study — Stavroula Α. Paschou (2022) | RDL Network
Patients with type 2 diabetes mellitus present similar immunological response to COVID-19 BNT162b2 mRNA vaccine to healthy subjects: a prospective cohort study
Article 2022 en
Authors
SP
Stavroula Α. Paschou
VK
Vangelis Karalis
ΘΨ
Θεοδώρα Ψαλτοπούλου
Abstract
1 min read
Patients with T2DM present similar immunological response to COVID-19 BNT162b2 mRNA vaccine to that of healthy subjects.
Gilad Itchaki, Lior Rokach, Ohad Benjamini, Osnat Bairey, Adi D. Sabag, Helly Vernitsky, Hagai Cohen, Shahar Rotem, Uri Elia, Pia Raanani, Erez Bar‐Haim, Tamar Tadmor
Discussion(0)
No comments yet. Be the first to comment.